none title certification

UAB "LEVIPHARM" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
2,540
2,540
957
-957
-957
-41.97
-37.68
5,077
540
0
5,617
2023
4,230
4,230
1
-1
-1
34.54
-0.02
5,077
1,603
0
6,680
2024
3,960
3,960
4,775
-4,775
-4,775
21.79
-120.58
341
883
0
1,224
unlock data icon

Register and

explore Okredo data
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

3,960 €Descended-6 % *

Sales per employee (€)

3,960 €Descended-6 % *

Profit before tax (€)

4,775 €Ascended477,400 % *

Net Profit (€)

-4,775 €Descended-477,400 % *

Profit per employee (€)

-4,775 €Descended-477,400 % *

Total profitability (%)

21.79 %Descended-36.91 % *

Net profitability (%)

-120.58 %Descended-602,800.00 % *

Equity (€)

341 €Descended-93 % *

Amounts Payable And Liabilities (€)

883 €Descended-45 % *

Non-current Assets (€)

0 €Ascended- *

CurrentAssets (€)

1,224 €Descended-82 % *

*over the last year starting selected period